Global Oral Delivery Vaccines Market Growth 2025-2031

The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pull Down Attic Ladder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pull Down Attic Ladder players cover Werner, Louisville Ladder, FAKRO, MSW, American Stairways, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pull Down Attic Ladder Industry Forecast” looks at past sales and reviews total world Pull Down Attic Ladder sales in 2024, providing a comprehensive analysis by region and market sector of projected Pull Down Attic Ladder sales for 2025 through 2031. With Pull Down Attic Ladder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pull Down Attic Ladder industry.
This Insight Report provides a comprehensive analysis of the global Pull Down Attic Ladder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pull Down Attic Ladder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pull Down Attic Ladder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pull Down Attic Ladder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pull Down Attic Ladder.
This report presents a comprehensive overview, market shares, and growth opportunities of Pull Down Attic Ladder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pull Down Attic Ladder market?
What factors are driving Pull Down Attic Ladder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pull Down Attic Ladder market opportunities vary by end market size?
How does Pull Down Attic Ladder break out by Type, by Application?
The global Pull Down Attic Ladder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pull Down Attic Ladder players cover Werner, Louisville Ladder, FAKRO, MSW, American Stairways, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pull Down Attic Ladder Industry Forecast” looks at past sales and reviews total world Pull Down Attic Ladder sales in 2024, providing a comprehensive analysis by region and market sector of projected Pull Down Attic Ladder sales for 2025 through 2031. With Pull Down Attic Ladder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pull Down Attic Ladder industry.
This Insight Report provides a comprehensive analysis of the global Pull Down Attic Ladder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pull Down Attic Ladder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pull Down Attic Ladder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pull Down Attic Ladder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pull Down Attic Ladder.
This report presents a comprehensive overview, market shares, and growth opportunities of Pull Down Attic Ladder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Wood
- Aluminum
- Steel
- Residential
- Commercial
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Werner
- Louisville Ladder
- FAKRO
- MSW
- American Stairways, Inc
- Dolle
- MARWIN
- Telesteps
- Duo-Safety Ladder Corporation
- Attic Ease
What is the 10-year outlook for the global Pull Down Attic Ladder market?
What factors are driving Pull Down Attic Ladder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pull Down Attic Ladder market opportunities vary by end market size?
How does Pull Down Attic Ladder break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Delivery Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Delivery Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Delivery Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Oral Delivery Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Delivery Vaccines Sales by Type
2.3.1 Global Oral Delivery Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Delivery Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Delivery Vaccines Sale Price by Type (2020-2025)
2.4 Oral Delivery Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Delivery Vaccines Sales by Application
2.5.1 Global Oral Delivery Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Delivery Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Delivery Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Delivery Vaccines Breakdown Data by Company
3.1.1 Global Oral Delivery Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Oral Delivery Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Oral Delivery Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Delivery Vaccines Revenue by Company (2020-2025)
3.2.2 Global Oral Delivery Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Oral Delivery Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Delivery Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Delivery Vaccines Product Location Distribution
3.4.2 Players Oral Delivery Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL DELIVERY VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Delivery Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Delivery Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Delivery Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Delivery Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Delivery Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Delivery Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Delivery Vaccines Sales Growth
4.4 APAC Oral Delivery Vaccines Sales Growth
4.5 Europe Oral Delivery Vaccines Sales Growth
4.6 Middle East & Africa Oral Delivery Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Delivery Vaccines Sales by Country
5.1.1 Americas Oral Delivery Vaccines Sales by Country (2020-2025)
5.1.2 Americas Oral Delivery Vaccines Revenue by Country (2020-2025)
5.2 Americas Oral Delivery Vaccines Sales by Type (2020-2025)
5.3 Americas Oral Delivery Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Delivery Vaccines Sales by Region
6.1.1 APAC Oral Delivery Vaccines Sales by Region (2020-2025)
6.1.2 APAC Oral Delivery Vaccines Revenue by Region (2020-2025)
6.2 APAC Oral Delivery Vaccines Sales by Type (2020-2025)
6.3 APAC Oral Delivery Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Delivery Vaccines by Country
7.1.1 Europe Oral Delivery Vaccines Sales by Country (2020-2025)
7.1.2 Europe Oral Delivery Vaccines Revenue by Country (2020-2025)
7.2 Europe Oral Delivery Vaccines Sales by Type (2020-2025)
7.3 Europe Oral Delivery Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Delivery Vaccines by Country
8.1.1 Middle East & Africa Oral Delivery Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Delivery Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Delivery Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Delivery Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Delivery Vaccines
10.3 Manufacturing Process Analysis of Oral Delivery Vaccines
10.4 Industry Chain Structure of Oral Delivery Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Delivery Vaccines Distributors
11.3 Oral Delivery Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL DELIVERY VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Delivery Vaccines Market Size Forecast by Region
12.1.1 Global Oral Delivery Vaccines Forecast by Region (2026-2031)
12.1.2 Global Oral Delivery Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Delivery Vaccines Forecast by Type (2026-2031)
12.7 Global Oral Delivery Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Delivery Vaccines Product Portfolios and Specifications
13.1.3 Merck Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Delivery Vaccines Product Portfolios and Specifications
13.2.3 GSK Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Delivery Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Delivery Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Delivery Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Delivery Vaccines Product Portfolios and Specifications
13.6.3 Valneva Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Delivery Vaccines Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Delivery Vaccines Product Portfolios and Specifications
13.8.3 Bibcol Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Delivery Vaccines Product Portfolios and Specifications
13.9.3 PaxVax Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Delivery Vaccines Product Portfolios and Specifications
13.10.3 Vabiotech Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Delivery Vaccines Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Delivery Vaccines Product Portfolios and Specifications
13.12.3 EuBiologics Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Delivery Vaccines Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Delivery Vaccines Product Portfolios and Specifications
13.14.3 Bio-Med Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Delivery Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Delivery Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Delivery Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Oral Delivery Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Delivery Vaccines Sales by Type
2.3.1 Global Oral Delivery Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Delivery Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Delivery Vaccines Sale Price by Type (2020-2025)
2.4 Oral Delivery Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Delivery Vaccines Sales by Application
2.5.1 Global Oral Delivery Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Delivery Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Delivery Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Delivery Vaccines Breakdown Data by Company
3.1.1 Global Oral Delivery Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Oral Delivery Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Oral Delivery Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Delivery Vaccines Revenue by Company (2020-2025)
3.2.2 Global Oral Delivery Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Oral Delivery Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Delivery Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Delivery Vaccines Product Location Distribution
3.4.2 Players Oral Delivery Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL DELIVERY VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Delivery Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Delivery Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Delivery Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Delivery Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Delivery Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Delivery Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Delivery Vaccines Sales Growth
4.4 APAC Oral Delivery Vaccines Sales Growth
4.5 Europe Oral Delivery Vaccines Sales Growth
4.6 Middle East & Africa Oral Delivery Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Delivery Vaccines Sales by Country
5.1.1 Americas Oral Delivery Vaccines Sales by Country (2020-2025)
5.1.2 Americas Oral Delivery Vaccines Revenue by Country (2020-2025)
5.2 Americas Oral Delivery Vaccines Sales by Type (2020-2025)
5.3 Americas Oral Delivery Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Delivery Vaccines Sales by Region
6.1.1 APAC Oral Delivery Vaccines Sales by Region (2020-2025)
6.1.2 APAC Oral Delivery Vaccines Revenue by Region (2020-2025)
6.2 APAC Oral Delivery Vaccines Sales by Type (2020-2025)
6.3 APAC Oral Delivery Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Delivery Vaccines by Country
7.1.1 Europe Oral Delivery Vaccines Sales by Country (2020-2025)
7.1.2 Europe Oral Delivery Vaccines Revenue by Country (2020-2025)
7.2 Europe Oral Delivery Vaccines Sales by Type (2020-2025)
7.3 Europe Oral Delivery Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Delivery Vaccines by Country
8.1.1 Middle East & Africa Oral Delivery Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Delivery Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Delivery Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Delivery Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Delivery Vaccines
10.3 Manufacturing Process Analysis of Oral Delivery Vaccines
10.4 Industry Chain Structure of Oral Delivery Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Delivery Vaccines Distributors
11.3 Oral Delivery Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL DELIVERY VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Delivery Vaccines Market Size Forecast by Region
12.1.1 Global Oral Delivery Vaccines Forecast by Region (2026-2031)
12.1.2 Global Oral Delivery Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Delivery Vaccines Forecast by Type (2026-2031)
12.7 Global Oral Delivery Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Delivery Vaccines Product Portfolios and Specifications
13.1.3 Merck Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Delivery Vaccines Product Portfolios and Specifications
13.2.3 GSK Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Delivery Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Delivery Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Delivery Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Delivery Vaccines Product Portfolios and Specifications
13.6.3 Valneva Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Delivery Vaccines Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Delivery Vaccines Product Portfolios and Specifications
13.8.3 Bibcol Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Delivery Vaccines Product Portfolios and Specifications
13.9.3 PaxVax Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Delivery Vaccines Product Portfolios and Specifications
13.10.3 Vabiotech Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Delivery Vaccines Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Delivery Vaccines Product Portfolios and Specifications
13.12.3 EuBiologics Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Delivery Vaccines Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Delivery Vaccines Product Portfolios and Specifications
13.14.3 Bio-Med Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Oral Delivery Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Delivery Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Oral Delivery Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Oral Delivery Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Oral Delivery Vaccines Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Oral Delivery Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Oral Delivery Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Oral Delivery Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Oral Delivery Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Oral Delivery Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Oral Delivery Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Oral Delivery Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Oral Delivery Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Oral Delivery Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Oral Delivery Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Oral Delivery Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Delivery Vaccines Products Offered
Table 23. Oral Delivery Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Delivery Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Oral Delivery Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Oral Delivery Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Oral Delivery Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Oral Delivery Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Oral Delivery Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Oral Delivery Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Oral Delivery Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Oral Delivery Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Oral Delivery Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Oral Delivery Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Oral Delivery Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Oral Delivery Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Oral Delivery Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Delivery Vaccines
Table 53. Key Market Challenges & Risks of Oral Delivery Vaccines
Table 54. Key IndustryTrends of Oral Delivery Vaccines
Table 55. Oral Delivery Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Delivery Vaccines Distributors List
Table 58. Oral Delivery Vaccines Customer List
Table 59. Global Oral Delivery Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Oral Delivery Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Oral Delivery Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Oral Delivery Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Oral Delivery Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Oral Delivery Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Oral Delivery Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Oral Delivery Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Oral Delivery Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Oral Delivery Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Oral Delivery Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Oral Delivery Vaccines Product Portfolios and Specifications
Table 75. Merck Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Oral Delivery Vaccines Product Portfolios and Specifications
Table 80. GSK Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Oral Delivery Vaccines Product Portfolios and Specifications
Table 85. Sanofi Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Lanzhou Institute Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Lanzhou Institute Oral Delivery Vaccines Product Portfolios and Specifications
Table 90. Lanzhou Institute Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Lanzhou Institute Main Business
Table 92. Lanzhou Institute Latest Developments
Table 93. Serum Institute Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Oral Delivery Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Valneva Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Oral Delivery Vaccines Product Portfolios and Specifications
Table 100. Valneva Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Valneva Main Business
Table 102. Valneva Latest Developments
Table 103. Shanghai United Cell Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai United Cell Oral Delivery Vaccines Product Portfolios and Specifications
Table 105. Shanghai United Cell Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Shanghai United Cell Main Business
Table 107. Shanghai United Cell Latest Developments
Table 108. Bibcol Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Bibcol Oral Delivery Vaccines Product Portfolios and Specifications
Table 110. Bibcol Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Bibcol Main Business
Table 112. Bibcol Latest Developments
Table 113. PaxVax Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. PaxVax Oral Delivery Vaccines Product Portfolios and Specifications
Table 115. PaxVax Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. PaxVax Main Business
Table 117. PaxVax Latest Developments
Table 118. Vabiotech Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Vabiotech Oral Delivery Vaccines Product Portfolios and Specifications
Table 120. Vabiotech Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Vabiotech Main Business
Table 122. Vabiotech Latest Developments
Table 123.Tiantan Biological Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124.Tiantan Biological Oral Delivery Vaccines Product Portfolios and Specifications
Table 125.Tiantan Biological Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126.Tiantan Biological Main Business
Table 127.Tiantan Biological Latest Developments
Table 128. EuBiologics Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. EuBiologics Oral Delivery Vaccines Product Portfolios and Specifications
Table 130. EuBiologics Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. EuBiologics Main Business
Table 132. EuBiologics Latest Developments
Table 133. Panacea Biotec Ltd Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Panacea Biotec Ltd Oral Delivery Vaccines Product Portfolios and Specifications
Table 135. Panacea Biotec Ltd Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Panacea Biotec Ltd Main Business
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Med Oral Delivery Vaccines Product Portfolios and Specifications
Table 140. Bio-Med Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Bio-Med Main Business
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Portfolios and Specifications
Table 145. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Halfkin Bio-Pharmaceuticals Main Business
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
.
Table 1. Oral Delivery Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Delivery Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Oral Delivery Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Oral Delivery Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Oral Delivery Vaccines Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Oral Delivery Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Oral Delivery Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Oral Delivery Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Oral Delivery Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Oral Delivery Vaccines Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Oral Delivery Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Oral Delivery Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Oral Delivery Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Oral Delivery Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Oral Delivery Vaccines Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Oral Delivery Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Delivery Vaccines Products Offered
Table 23. Oral Delivery Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Delivery Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Oral Delivery Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Oral Delivery Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Oral Delivery Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Oral Delivery Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Oral Delivery Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Oral Delivery Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Oral Delivery Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Oral Delivery Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Oral Delivery Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Oral Delivery Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Oral Delivery Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Oral Delivery Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Oral Delivery Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Oral Delivery Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Oral Delivery Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Oral Delivery Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Delivery Vaccines
Table 53. Key Market Challenges & Risks of Oral Delivery Vaccines
Table 54. Key IndustryTrends of Oral Delivery Vaccines
Table 55. Oral Delivery Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Delivery Vaccines Distributors List
Table 58. Oral Delivery Vaccines Customer List
Table 59. Global Oral Delivery Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Oral Delivery Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Oral Delivery Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Oral Delivery Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Oral Delivery Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Oral Delivery Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Oral Delivery Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Oral Delivery Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Oral Delivery Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Oral Delivery Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Oral Delivery Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Oral Delivery Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Oral Delivery Vaccines Product Portfolios and Specifications
Table 75. Merck Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Oral Delivery Vaccines Product Portfolios and Specifications
Table 80. GSK Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Oral Delivery Vaccines Product Portfolios and Specifications
Table 85. Sanofi Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Lanzhou Institute Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Lanzhou Institute Oral Delivery Vaccines Product Portfolios and Specifications
Table 90. Lanzhou Institute Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Lanzhou Institute Main Business
Table 92. Lanzhou Institute Latest Developments
Table 93. Serum Institute Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Oral Delivery Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Valneva Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Oral Delivery Vaccines Product Portfolios and Specifications
Table 100. Valneva Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Valneva Main Business
Table 102. Valneva Latest Developments
Table 103. Shanghai United Cell Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai United Cell Oral Delivery Vaccines Product Portfolios and Specifications
Table 105. Shanghai United Cell Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Shanghai United Cell Main Business
Table 107. Shanghai United Cell Latest Developments
Table 108. Bibcol Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Bibcol Oral Delivery Vaccines Product Portfolios and Specifications
Table 110. Bibcol Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Bibcol Main Business
Table 112. Bibcol Latest Developments
Table 113. PaxVax Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. PaxVax Oral Delivery Vaccines Product Portfolios and Specifications
Table 115. PaxVax Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. PaxVax Main Business
Table 117. PaxVax Latest Developments
Table 118. Vabiotech Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Vabiotech Oral Delivery Vaccines Product Portfolios and Specifications
Table 120. Vabiotech Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Vabiotech Main Business
Table 122. Vabiotech Latest Developments
Table 123.Tiantan Biological Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124.Tiantan Biological Oral Delivery Vaccines Product Portfolios and Specifications
Table 125.Tiantan Biological Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126.Tiantan Biological Main Business
Table 127.Tiantan Biological Latest Developments
Table 128. EuBiologics Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. EuBiologics Oral Delivery Vaccines Product Portfolios and Specifications
Table 130. EuBiologics Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. EuBiologics Main Business
Table 132. EuBiologics Latest Developments
Table 133. Panacea Biotec Ltd Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Panacea Biotec Ltd Oral Delivery Vaccines Product Portfolios and Specifications
Table 135. Panacea Biotec Ltd Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Panacea Biotec Ltd Main Business
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Med Oral Delivery Vaccines Product Portfolios and Specifications
Table 140. Bio-Med Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Bio-Med Main Business
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Oral Delivery Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Product Portfolios and Specifications
Table 145. Halfkin Bio-Pharmaceuticals Oral Delivery Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Halfkin Bio-Pharmaceuticals Main Business
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Delivery Vaccines
Figure 2. Oral Delivery Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Delivery Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oral Delivery Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Delivery Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Delivery Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Oral Delivery Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of Oral Polio Vaccine
Figure 14. Global Oral Delivery Vaccines Sales Market Share byType in 2025
Figure 15. Global Oral Delivery Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Oral Delivery Vaccines Consumed in Public
Figure 17. Global Oral Delivery Vaccines Market: Public (2020-2025) & (K Units)
Figure 18. Oral Delivery Vaccines Consumed in Private
Figure 19. Global Oral Delivery Vaccines Market: Private (2020-2025) & (K Units)
Figure 20. Global Oral Delivery Vaccines Sale Market Share by Application (2024)
Figure 21. Global Oral Delivery Vaccines Revenue Market Share by Application in 2025
Figure 22. Oral Delivery Vaccines Sales by Company in 2025 (K Units)
Figure 23. Global Oral Delivery Vaccines Sales Market Share by Company in 2025
Figure 24. Oral Delivery Vaccines Revenue by Company in 2025 ($ millions)
Figure 25. Global Oral Delivery Vaccines Revenue Market Share by Company in 2025
Figure 26. Global Oral Delivery Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Oral Delivery Vaccines Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 29. Americas Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 30. APAC Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 31. APAC Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 32. Europe Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 33. Europe Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Americas Oral Delivery Vaccines Sales Market Share by Country in 2025
Figure 37. Americas Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Figure 38. Americas Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 39. Americas Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 40. United States Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Oral Delivery Vaccines Sales Market Share by Region in 2025
Figure 45. APAC Oral Delivery Vaccines Revenue Market Share by Region (2020-2025)
Figure 46. APAC Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 47. APAC Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 48. China Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. India Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Oral Delivery Vaccines Sales Market Share by Country in 2025
Figure 56. Europe Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Europe Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 58. Europe Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Germany Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60.France Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Oral Delivery Vaccines Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 67. Egypt Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Delivery Vaccines in 2025
Figure 73. Manufacturing Process Analysis of Oral Delivery Vaccines
Figure 74. Industry Chain Structure of Oral Delivery Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Delivery Vaccines Sales MarketForecast by Region (2026-2031)
Figure 77. Global Oral Delivery Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Oral Delivery Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Oral Delivery Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Oral Delivery Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Oral Delivery Vaccines Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Oral Delivery Vaccines
Figure 2. Oral Delivery Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Delivery Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oral Delivery Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Delivery Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Delivery Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Oral Delivery Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of Oral Polio Vaccine
Figure 14. Global Oral Delivery Vaccines Sales Market Share byType in 2025
Figure 15. Global Oral Delivery Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Oral Delivery Vaccines Consumed in Public
Figure 17. Global Oral Delivery Vaccines Market: Public (2020-2025) & (K Units)
Figure 18. Oral Delivery Vaccines Consumed in Private
Figure 19. Global Oral Delivery Vaccines Market: Private (2020-2025) & (K Units)
Figure 20. Global Oral Delivery Vaccines Sale Market Share by Application (2024)
Figure 21. Global Oral Delivery Vaccines Revenue Market Share by Application in 2025
Figure 22. Oral Delivery Vaccines Sales by Company in 2025 (K Units)
Figure 23. Global Oral Delivery Vaccines Sales Market Share by Company in 2025
Figure 24. Oral Delivery Vaccines Revenue by Company in 2025 ($ millions)
Figure 25. Global Oral Delivery Vaccines Revenue Market Share by Company in 2025
Figure 26. Global Oral Delivery Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Oral Delivery Vaccines Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 29. Americas Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 30. APAC Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 31. APAC Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 32. Europe Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 33. Europe Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Oral Delivery Vaccines Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Oral Delivery Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Americas Oral Delivery Vaccines Sales Market Share by Country in 2025
Figure 37. Americas Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Figure 38. Americas Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 39. Americas Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 40. United States Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Oral Delivery Vaccines Sales Market Share by Region in 2025
Figure 45. APAC Oral Delivery Vaccines Revenue Market Share by Region (2020-2025)
Figure 46. APAC Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 47. APAC Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 48. China Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. India Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Oral Delivery Vaccines Sales Market Share by Country in 2025
Figure 56. Europe Oral Delivery Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Europe Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 58. Europe Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Germany Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60.France Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Oral Delivery Vaccines Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Oral Delivery Vaccines Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Oral Delivery Vaccines Sales Market Share by Application (2020-2025)
Figure 67. Egypt Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Oral Delivery Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Delivery Vaccines in 2025
Figure 73. Manufacturing Process Analysis of Oral Delivery Vaccines
Figure 74. Industry Chain Structure of Oral Delivery Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Delivery Vaccines Sales MarketForecast by Region (2026-2031)
Figure 77. Global Oral Delivery Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Oral Delivery Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Oral Delivery Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Oral Delivery Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Oral Delivery Vaccines Revenue Market ShareForecast by Application (2026-2031)